SMavula Colored Photo

Sarah Mavula

Baker & McKenzie LLP


Sarah Mavula is a senior associate in Baker McKenzie's International Commercial Practice Group and the Global Antitrust & Competition Group in Toronto. Recognized as a 2022 Precedent Setter in Precedent Magazine's Precedent Setter Awards, Sarah practices competition/antitrust and foreign investment law. Sarah also regularly advises clients on product regulatory compliance. 

Practice Focus

Sarah regularly advises clients in a variety of industries on Canadian and international merger control, foreign investment and national security in corporate and commercial transactions. As part of her competition practice, Sarah routinely secures merger control clearances, and advises on pricing policies, competitor collaborations, abuse of dominance, and compliance programs. Her extensive experience in foreign investment matters under the Investment Canada Act includes assisting clients with the preparation of review applications and notifications (including under new COVID-19 policies), drafting and negotiating undertakings, and securing national security clearance for her clients.

As part of Sarah’s complimentary practice, she assists international businesses with the commercial and regulatory aspects of expanding to Canada, and from Canada to other markets. In doing so, she advises extensively on advertising and marketing law through all media types, focusing on a wide array of areas, including deceptive marketing, contests, sweepstakes and promotions, consumer protection, privacy and anti-spam laws, technology, communications and online sales regulation, and product regulatory compliance involving food, cosmetics, drugs, medical devices, and other consumer and industrial products.

Representative Legal Matters

  • Secured Canadian merger clearance for Trillium Pharmaceutical, a clinical-stage blood cancer treatment company, in its nearly USD 2.3 billion acquisition by pharmaceutical giant Pfizer Inc.

  • Provided Canadian antitrust and foreign investment advice in Chiesi Farmaceutici S.p.A.'s, an international research-focused healthcare group, acquisition of Apotex Inc.'s global rights to deferiprone, an iron chelator used to treat iron overload conditions resulting from blood transfusions.

  • Assisted a multinational pharmaceutical company in connection with antitrust and foreign investment clearance for the USD 55 million sale of one of its Canadian manufacturing facilities, which was scrutinized under national security laws as a result of the sensitive pharmaceutical sector. Obtained national security clearance under the Investment Canada Act.

  • Secured national security clearance for a nearly USD 110 million transaction involving the acquisition of a high-grade metal processing facility subject to the federal government's Critical Mineral List.

  • Advised a multinational entertainment company in its minority acquisition of a Canadian video games publisher, and obtained national security clearance.

  • Advised Hitachi on Canadian competition and foreign investment law in its USD 8.1 billion acquisition of ABB's power grids business (the largest ever acquisition by a Japanese industrial company).

  • Represented Impala Platinum Holdings Limited, one of the world’s foremost producers of platinum, on Canadian merger control filings and foreign investment law in its acquisition of North American Palladium.

  • Represented a leading US-based hospitality group in its merger clearance of its non-notifiable acquisition of a Canadian target.

  • Advised DIF Capital Partners on the Canadian foreign investment and merger control filings in connection with its acquisition, through DIF Infrastructure V, of BluEarth Renewables LP from Ontario Teachers' Pension Plan.

  • Represented Platinum Equity in its USD 3.8 billion acquisition of Husky IMS International Ltd., the Canada-headquartered global leader in the manufacture and supply of injection molding equipment to the plastics industry. The acquisition involved obtaining both merger clearance under the Competition Act and foreign investment approval under the Investment Canada Act.

  • Advised a leading US-based data communications and telecommunications equipment provider on its USD 1.2 billion cross-border acquisition of a Canadian manufacturer of advanced video surveillance solutions listed on the Toronto Stock Exchange.

  • Represented a major private equity fund on Canadian competition and foreign investment law in its acquisition of a leading supplier of injection molding equipment and services.

  • Advised a leading luxury wine and spirit company of its Canadian alcohol marketing practices.

  • Advised a leading video game platform in connection with its Canadian expansion, focusing on Canadian youth protection laws, and related privacy and marketing laws.

  • Provide ongoing advice to a major consumer goods company on its cross-border marketing practices with respect to Quebec’s French language requirements.

  • Provide ongoing advice to major food manufacturers regarding their food regulatory and marketing requirements.

Professional Associations and Memberships

  • Law Society of Upper Canada
  • Canadian Bar Association
  • Ontario Bar Association
  • American Bar Association (Section of Antitrust Law)


  • Ontario~Canada (2016)


  • Ottawa University (J.D.) (2015)
  • Ottawa University (BSc. Chemistry) (2012)


  • English
  • French